With the acquisition, Medifarma will have around 20% of the condom market.

The Drokasa laboratory sold its condom business, including the Gents and Zensex brands, for an undisclosed amount to the pharmaceutical company Medifarma, a company that entered this market last year with the Legend condom brand, according to Lex Latin. The firm Drokasa was advised by the Rubio Leguía Normand studio.

With the acquisition, Medifarma will have around 20% market in condoms, which would place them as the second most important players in the market, according to the newspaper Gestión. In the first place, Condones Piel is located, with 41% market share. This brand is marketed by the Apropo organization, oriented to the promotion of responsible health and sexuality culture.

Medifarma – which in 2017 reported revenues of S / 417.5 million, 2.3% less than the previous year – has the line of condoms within its mass consumption division, made up of about 20 brands such as Sal de Andrews or Milk of Magnesia.